More Americans are about to get scammed by the coming peptide rush
Patients will order these cheaper, unproven products via an 800-number or the internet, skipping appointments with real doctors who can provide accurate diagnoses and proven treatments.
Read Full Article on MarketWatchAI SUMMARY
# Summary As unregulated peptide products gain popularity through direct-to-consumer marketing channels, patients are bypassing legitimate medical oversight to purchase cheaper, unproven alternatives, potentially creating a significant market opportunity for illicit supplement sellers while exposing the pharmaceutical and telehealth industries to reputational and regulatory risk. This trend could divert spending from FDA-approved treatments and established healthcare providers, though no specific company valuations or market share data are provided in the article description.
More Top Stories News
Like Costco, Walmart will sell Medicare Advantage plans
Micron, Intel and other chip stocks are furthering their strong comebacks
The smartest money moves to make now that interest rates are going up
‘I just want out’: Why Jeffrey Gundlach is moving his money as far from AI as possible — and what he’s doing instead
How can I get my employees to stop oversharing at work?
Content sourced from MarketWatch. Not financial advice.